未登录

M

Mauricio Cabrera

universidad de la republica, uruguay

H指数:19

被引数:1,137

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Flavonoid-Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis

IF3.4

2024-08-090

PRE

Phenotypic and Target-Directed Screening Yields New Acaricidal Alternatives for the Control of Ticks

IF4.6

2022-12-131

OAAI

Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity

具有抗trematode活性的新型选择性磷酸丙糖异构酶灭活剂

SCIENTIFIC REPORTS

IF3.9

2020-02-1315

OAAI

Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-N-Oxide Derivatives

IF4.6

2019-06-268

OAAI

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2017-12-2256

PREAI

Small-Molecule Kinase-Inhibitors-Loaded Boron Cluster as Hybrid Agents for Glioma-Cell-Targeting Therapy

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2017-07-0350

PREAI

Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach

PLOS NEGLECTED TROPICAL DISEASES

IF3.4

2016-07-2721

OAAI

In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2016-04-0122

PREAI

3-H-[1,2] Dithiole as a New Anti-Trypanosoma cruzi Chemotype: Biological and Mechanism of Action Studies

IF4.6

2015-08-1213

OAAI

Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents

FUTURE MEDICINAL CHEMISTRY

IF3.4

2015-06-1013

PREAI

A serendipitous one-step conversion of 3H-1,2-dithiole-3-thione to (E)-3-[1-(alkylthio)alkylidene]-3H-1,2-dithiole: an experimental and theoretical study

MOLECULAR DIVERSITY

IF3.8

2014-01-145

PREAI

Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2012-03-0168

PRE

3-Trifluoromethylquinoxaline N,N′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action Studies

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2011-05-0457

OAAI

Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2010-12-0142

PREAI

Structural modifications on the phenazine N,N′-dioxide-scaffold looking for new selective hypoxic cytotoxins

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2010-11-0128

PREAI

Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2010-07-0126

PRE

Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2010-06-1525

PRE

Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2009-02-0128

PRE

Differential enzymatic reductions governing the differential hypoxia-selective cytotoxicities of phenazine 5,10-dioxides

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2008-07-2931

PREAI

New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents

JOURNAL OF INORGANIC BIOCHEMISTRY

IF3.2

2008-01-0164

PREAI